Decanoylcarnitine Improves Liver Mitochondrial Dysfunction in Hepatitis B Virus Infection by Enhancing Fatty Acid β-Oxidation - Top-Institutions - MDSpire

Decanoylcarnitine Improves Liver Mitochondrial Dysfunction in Hepatitis B Virus Infection by Enhancing Fatty Acid β-Oxidation

  • By

  • Ye Sun

  • Qingling Chen

  • Yuxiao Liu

  • Mengfan Jiao

  • Zixing Dai

  • Xiaoxue Hou

  • Rui Liu

  • Yuwen Li

  • Chuanlong Zhu

  • January 8, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas Southwestern Medical Center
    The University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Hepatology
    • Metabolic Liver Disease
    • Virology

  • #2

    Mount Sinai Health System, Icahn School of Medicine
    Mount Sinai Health System, Icahn School of Medicine

    New York, NY

    Key Differentiators

    • Hepatology
    • Mitochondrial Biology
    • Metabolism

  • #3

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH

    Bethesda, MD

    Key Differentiators

    • Hepatology
    • Metabolic Disease Research
    • Mitochondrial Function

  • #4

    Peking University Health Science Center
    Peking University Health Science Center

    Beijing, Beijing

    Key Differentiators

    • Hepatology
    • Virology
    • Metabolic Liver Disease

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Hepatology
    • Mitochondrial Biology
    • Metabolic Disorders

Original Source(s)

Decanoylcarnitine Improves Liver Mitochondrial Dysfunction in Hepatitis B Virus Infection by Enhancing Fatty Acid β-Oxidation

  • by Ye Sun, Qingling Chen, Yuxiao Liu, Mengfan Jiao, Zixing Dai, Xiaoxue Hou, Rui Liu, Yuwen Li, Chuanlong Zhu

  • January 8, 2025

Related Content

Evaluation of Liver Fibrosis Change After DAA-induced Cure of Hepatitis C in Participants With and Without HIV: ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (VHICS)

High Seroprevalence of Hepatitis E Virus Among Patients With Hepatitis B and Those With Hepatitis of Unknown Etiology in Central Vietnam

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.